Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Nov 02 2022
Business
Nov 2 2022
5 min read

Press Release Nov 02 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 02-Nov-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Mesalamine Extended-Release Capsules USP, 0.375 g.

View Attachment